The independent source for health policy research, polling, and news.
961 - 980 of 3,920 Results
A group of former professional athletes traveled to Jamaica to try psychedelics as a way to help cope with the aftereffects of concussions and a career of body-pounding injuries. Will this still largely untested treatment work?
The private equity-backed practice has been known to demand more than $100,000 in charges or penalties. One patient is fighting back.
Lisa French was told her surgery would cost $1,337. But the hospital sent her a bill for $229,000, then sued her. The case went all the way to the Colorado Supreme Court. The court’s ruling could have major implications for determining a “reasonable price” in health care.
Advocates for improving rural health pushed for the CDC to extend its rural health focus by creating an Office of Rural Health. They hope the agency will commit to rural health research and provide analyses that lead to good public health policies for rural communities.
Online platforms are overflowing with testimonials for GLP-1s. The drugs show promise for inducing weight loss, but many aren’t FDA-approved for that use.
The median life expectancy for a U.S. baby born with Down syndrome jumped from about four years in 1950 to 58 years in the 2010s. That’s largely because they no longer can be denied lifesaving care, including surgeries for heart defects. But now, aging adults with Down syndrome face a health system unprepared to care for them.
Horizon Therapeutics, which Amgen is acquiring for about $28 billion, grew large by snapping up cheap drugs from other companies, marketing them to perfection, and jacking up prices.
KFF Health News and CBS News recently reported that multiple lawsuits allege the device has led to grievous injuries to patients’ mouths, resulting in loss of teeth.
One of Montana’s largest mental health providers has ratcheted back services amid financial troubles, leaving a vacuum. State policymakers have promised more money to aid behavioral health care, but lasting change could be years out.
The American Medical Association ducked the abortion issue for years and now sees its members’ professional opinions second-guessed by lawmakers and judges. PhRMA is following the same playbook.
A federal judge’s recent ruling on the Affordable Care Act is by no means the final word. Even parsing its impact is complicated. Here are key issues to watch as the case works its way through the legal system.
As of April 1, states were allowed to begin reevaluating Medicaid eligibility for millions of Americans who qualified for the program during the covid-19 pandemic but may no longer meet the income or other requirements. As many as 15 million people could lose health coverage as a result. Meanwhile, the Medicare Hospital Insurance Trust Fund is projected to stay solvent until 2031, its trustees reported, taking some pressure off of lawmakers to finally fix that program’s underlying financial weaknesses. Alice Miranda Ollstein of Politico, Rachel Roubein of The Washington Post, and Amy Goldstein of The Washington Post join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Daniel Chang, who reported the latest KHN-NPR “Bill of the Month” feature about a child not yet old enough for kindergarten whose medical bill landed him in collections.
A recent policy change in Minnesota promotes quick evaluations and care for people with substance use disorders. But because of gaps riddling rural treatment systems nationwide, the promise of swift care isn’t reaching rural Minnesotans.
At least eight states have implemented or are considering limits on what patients can be billed for the use of a hospital’s facilities even without having stepped foot in the building.
A KHN and CBS News investigation found that a dental appliance called the AGGA has been used by more than 10,000 patients, and multiple lawsuits allege it has caused grievous harm to patients.
A U.S. District Court ruling overturned the section of the Affordable Care Act that makes preventive health services — from colonoscopies to diabetes screenings and more — available at no cost to consumers.
Pharmaceutical companies have put the brakes on many states’ ability to execute prisoners using lethal injections. Lacking alternatives, states are trying to keep the public from learning details about how they carry out executions.
Hospitals are facing mixed reviews regarding their efforts to comply with a federal requirement that they post information about prices related to nearly every health care service they provide.
A federal lawmaker has introduced a House bill that would close one of a laundry list of oversight gaps revealed in a recent KHN investigation of the system regulators use to ban fraudsters from billing government health programs, including Medicare and Medicaid.
It’s about the money — on both sides — as arguments swirl about patient safety, rising prices, and paying back on-the-job training.
© 2026 KFF